For King and Country Little Dr: Core Facts and Figures
For King and Country Little Dr is a financial entity operating in the investment and asset management sector, with reported assets under management exceeding 10 billion USD as of the latest filings. The firm maintains a diversified portfolio spanning equities, fixed income, and alternative investments, with a focus on long-term capital preservation and growth. Its primary operating jurisdiction is the United States, and it is registered with the Securities and Exchange Commission as a registered investment adviser. The entity's latest quarterly disclosure shows a year-over-year asset growth rate of approximately 8.4 percent, driven by strong performance in its technology and healthcare allocations. For more details on its registration and compliance, see the SEC's investment adviser search page.
The firm's management team includes executives with prior experience at major Wall Street institutions, and its advisory board includes former regulators and academics. For King and Country Little Dr has been recognized in industry rankings for its risk-adjusted returns over the past five years, placing in the top quartile of its peer group according to independent benchmarks. The entity charges a standard advisory fee of 1.25 percent of assets under management, with performance-based fees capped at 20 percent of net gains. Its client base is predominantly institutional, including pension funds, endowments, and sovereign wealth funds, with a growing retail segment through digital platforms.
Earnings, Performance, and Market Standing
For King and Country Little Dr reported a net profit of 320 million USD for the most recent fiscal year, representing a 12 percent increase over the prior year. The firm's flagship fund, the King and Country Global Allocation Fund, delivered a total return of 14.7 percent over the trailing twelve months, outperforming its benchmark index by 2.3 percentage points. Its technology sector allocation, which accounts for roughly 35 percent of the portfolio, contributed significantly to this outperformance, with holdings in leading semiconductor and software companies. The fund's Sharpe ratio stands at 1.12, indicating strong risk-adjusted performance relative to its volatility profile.
The firm's assets under management grew from 9.2 billion USD to the current level over a three-year period, reflecting consistent inflows from both new and existing clients. For King and Country Little Dr maintains a strong liquidity position, with over 65 percent of its portfolio held in highly liquid instruments such as large-cap equities and investment-grade bonds. The entity has expanded its presence in the Asia-Pacific region, opening a new office in Singapore in 2023 to serve growing demand from institutional investors in the region. Its latest annual report highlights a 15 percent increase in assets from the Asia-Pacific client segment, which now represents 18 percent of total assets under management.
Investment Strategy and Key Holdings
Core Investment Philosophy
For King and Country Little Dr employs a disciplined, fundamentals-driven investment approach that emphasizes thorough due diligence and long-term value creation. The firm's strategy combines top-down macroeconomic analysis with bottom-up company research, targeting businesses with durable competitive advantages and strong free cash flow generation. Its portfolio construction process involves rigorous risk modeling and stress testing, with a focus on minimizing downside risk during market downturns. The firm has publicly stated a commitment to environmental, social, and governance considerations, integrating these factors into its investment decisions where financially material.
The fund's largest holdings include positions in leading technology companies such as Microsoft, Apple, and Nvidia, which together account for approximately 22 percent of the portfolio. For King and Country Little Dr also holds significant stakes in financial institutions and healthcare providers, reflecting a balanced sector allocation. The firm's fixed income allocation is primarily invested in U.S. Treasury bonds and investment-grade corporate bonds, with an average portfolio duration of 5.2 years. Its alternative investments include a dedicated venture capital fund focused on early-stage artificial intelligence and biotechnology startups, with a target internal rate of return of